Researchers have an ethical obligation to disclose the availability of off-label marketed drugs

Authors

Tomas J. Silber, George Washington UniversityFollow

Document Type

Response or Comment

Publication Date

4-2014

Journal

American Journal of Bioethics

Volume

Volume 14, Issue 4

Inclusive Pages

52

Keywords

Clinical Trials as Topic--ethics; Health Services Accessibility; Informed Consent--ethics; Moral Obligations; Off-Label Use; Research Personnel--ethics; Truth Disclosure--ethics

Comments

Comment on

The ethics of disclosing to research subjects the availability of off-label marketed drugs. [Am J Bioeth. 2014]

APA Citation

Silber, T.J. (2014). Researchers have an ethical obligation to disclose the availability of off-label marketed drugs. American Journal of Bioethics, 14(4), 52.